Corrigendum to "Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury" [Pharmacol. Res. 123 (2017) 83-92]
Saved in:
Main Authors: | Enrico Gugliandolo (Author), Roberta Fusco (Author), Flavia Biundo (Author), Ramona D'Amico (Author), Filippo Benedetto (Author), Rosanna Di Paola (Author), Salvatore Cuzzocrea (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
by: Rosanna Di Paola, et al.
Published: (2016) -
PEA/Polydatin: Anti-Inflammatory and Antioxidant Approach to Counteract DNBS-Induced Colitis
by: Alessio Filippo Peritore, et al.
Published: (2021) -
Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D'Amico, et al.
Published: (2021) -
Corrigendum to "Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects" [Pharmacol. Res. 60 (2009) 159-169]
by: Clara De Palma, et al.
Published: (2023) -
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019)